The first version of the annual report will be published this week. Usually, there is no news; they have been published earlier. However, I am waiting for some hidden issues regarding the possible PBT2 deal with this new company working with PBT2. The other interesting thing is the patent foulder, any new patents for ATH434? I also hope that the company tells more about the preclinical studies it has done with 434, but it has not been the habit in the last years.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.001(4.17%) |
Mkt cap ! $115.1M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $23.62K | 1.963M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 13709491 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 9965135 | 14 |
View Market Depth
| Last trade - 15.59pm 12/09/2025 (20 minute delay) ? |
| ATH (ASX) Chart |